Publication: Cell & Gene Therapy Review
Certara’s Fran Brown provides pivotal insights into the challenges poised to shape the cell and gene therapy landscape in 2025—particularly emphasizing commercial viability hurdles. The discussion revolves around innovative strategies to overcome these roadblocks, empowering the industry to advance breakthrough therapies while ensuring patient access remains at the forefront.
Published: 2025 年 2 月 3 日
了解更多关于细胞与基因治疗服务
Certara 是您推进细胞与基因治疗项目的可靠合作伙伴。凭借无与伦比的药物开发专长、创新建模技术及成功实践验证，我们助您驾驭这一新兴领域的复杂性。让我们携手将变革性疗法惠及患者。
